Detalhe da pesquisa
1.
The MYRACLE protocol study: a multicentric observational prospective cohort study of patients with multiple myeloma.
BMC Cancer
; 19(1): 855, 2019 Aug 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31464608
2.
Pomalidomide, cyclophosphamide, and dexamethasone for relapsed/refractory multiple myeloma patients in a real-life setting: a single-center retrospective study.
Ann Hematol
; 98(6): 1441-1447, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30874851
3.
Single-agent daratumumab in very advanced relapsed and refractory multiple myeloma patients: a real-life single-center retrospective study.
Ann Hematol
; 98(6): 1435-1440, 2019 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-30874850
4.
Update on elotuzumab for the treatment of relapsed/refractory multiple myeloma: patients' selection and perspective.
Onco Targets Ther
; 12: 5813-5822, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31410026